Watch Demo

Australia Anti-Infective Industry Outlook 2024 - 2028

See how Australia Anti-Infective performed compared to key markets such as Italy, Spain and Croatia.

Key Market Indicators

Australian Antiinfective Medicine Sales is projected to climb to $1.43 billion by 2028, up from $1.3 billion in 2023. This marks an average annual growth rate of 1.5%. However, since 1995, the Australian market has seen a slight decline of 0.6% per year. In the global rankings for 2023, Australia holds the fourth position, trailing behind Croatia, which also recorded $1.3 billion. Spain and Croatia occupy the second and third spots, respectively. In terms of exports, Australian antibiotics are expected to reach $13.3 million by 2028, increasing from $11.8 million in 2023. This indicates an average annual growth of 1.7%. Since 1993, the country's supply of antibiotics has grown by 1.8% annually. On the import front, Australian antibiotics are anticipated to drop to $15.6 million by 2028, down from $39 million in 2023. This represents a significant annual decline of 14.6%. Since 1993, the demand for imported antibiotics in Australia has decreased by 7.1% per year.

Marketing Banner

Australia Anti-Infective Market Data and Forecasts

How much will Australia Anti-Infective Market grow to 2028?

Forecast: Import of Antibiotics to Australia
Forecast: Export of Antibiotics from Australia
Forecast: Import of Tetracyclines to Australia
More in Anti-Infective Industry for 2028